Thursday, August 22, 2019
Cadden House Price Drops Again
By Walter F. Roche Jr.
The asking price on the mansion owned by a jailed former drug executive has dropped for the second time in recent months with the new price tag nearly $1.5 million below the original.
Real estate listings for the home of Barry J. Cadden, located in suburban Boston, show a new sales price of $1.5 million, compared to the original price of nearly $3 million. The house has been on the market for 238 days.
Cadden is serving a nine year prison sentence following his conviction on racketeering, conspiracy and mail fraud charges. His 9,000 square foot home is subject to a forfeiture order and half the proceeds will go to the federal government. The new lower price was set earlier this week.
Cadden was president and part owner of the New England Compounding Center, the Framingham, Mass. firm that caused a deadly 2012 fungal meningitis outbreak.
Featuring a pool and a five car garage, the property is described as a "magnificent estate" with a salt water pool, 5 bedrooms and a five car garage.
Prosecutors also sought $74 million in restitution from Cadden, but that motion has been put on hold by U.S. District Judge Richard G. Stearns.
The forfeiture order was initially $7.5 million but it was reduced substantially under a negotiated settlement between lawyers for the Cadden family and prosecutors.
Contact: wfrochejr999@gmail.com
Saturday, August 17, 2019
Judge Sets Appeal Date
By Walter F. Roche Jr,
A federal judge has set a Sept. 20 hearing date for appeals filed by two former employees of a drug compounding company blamed for a deadly 2012 fungal meningitis outbreak.
In an order filed this week U.S. District Judge Richard G. Stearns set the date for the appeals filed by Kathy Chin, 47, and Michelle Thomas, 35. The two were convicted on charges that they violated the Food Drug and Cosmetic Act, when they filled prescriptions made out for obviously fictitious patients.
Previously Stearns postponed indefinitely a sentencing session for the two, who were employed as pharmacists at the now defunct New England Compounding Center.
Chin was convicted on four counts of misbranding a drug with the intent to defraud while Thomas was found guilty of two counts of the same charges. The unanimous guilty verdicts were returned on May 2 after only two hours of deliberation.
Chin and Thomas were not charged for any involvement in producing the drugs that caused the outbreak but for filling prescriptions made out to obviously fake named patients, such as Filet O Fish.
Chin and Thomas were convicted on May 2. They were among 14 former NECC employees indicted following a two year probe of the outbreak.
The jury deliberated for only two hours before returning the unanimous verdicts.
Stearns already has granted appeals for two other NECC defendants, Gregory Conigliaro and Sharon Carter. They were both acquitted on all charges despite unanimous jury verdicts finding them guilty.
Kathy Chin is the wife of Glenn Chin, who was a supervising pharmacist at NECC. He is serving an eight year prison term following his conviction on racketeering, conspiracy and mail fraud charges.
Contact: wfrochejr999@gmail.com
A federal judge has set a Sept. 20 hearing date for appeals filed by two former employees of a drug compounding company blamed for a deadly 2012 fungal meningitis outbreak.
In an order filed this week U.S. District Judge Richard G. Stearns set the date for the appeals filed by Kathy Chin, 47, and Michelle Thomas, 35. The two were convicted on charges that they violated the Food Drug and Cosmetic Act, when they filled prescriptions made out for obviously fictitious patients.
Previously Stearns postponed indefinitely a sentencing session for the two, who were employed as pharmacists at the now defunct New England Compounding Center.
Chin was convicted on four counts of misbranding a drug with the intent to defraud while Thomas was found guilty of two counts of the same charges. The unanimous guilty verdicts were returned on May 2 after only two hours of deliberation.
Chin and Thomas were not charged for any involvement in producing the drugs that caused the outbreak but for filling prescriptions made out to obviously fake named patients, such as Filet O Fish.
Chin and Thomas were convicted on May 2. They were among 14 former NECC employees indicted following a two year probe of the outbreak.
The jury deliberated for only two hours before returning the unanimous verdicts.
Stearns already has granted appeals for two other NECC defendants, Gregory Conigliaro and Sharon Carter. They were both acquitted on all charges despite unanimous jury verdicts finding them guilty.
Kathy Chin is the wife of Glenn Chin, who was a supervising pharmacist at NECC. He is serving an eight year prison term following his conviction on racketeering, conspiracy and mail fraud charges.
Contact: wfrochejr999@gmail.com
Tuesday, August 13, 2019
Cadden Coastal Property Sold to Trust
By Walter F. Roche Jr.
The deed on a valuable coastal home owned by a jailed drug compounding executive and once the subject of a $7.5 million forfeiture order has been transferred to a real estate trust headed by one of the executive's sons.
Property records in Rhode Island show the home at 25 Newport Ave. in North Kingston was transferred from Barry J. Cadden and his wife to the Mele Nominee Trust with Matthew Cadden as the trustee. Matthew Cadden has been identified in court filings as Barry Cadden's son.
The deed transfer was filed on April 25 of this year, according to the North Kingston Assessor's office.
A forfeiture order filed in Barry Cadden's criminal case listed the Rhode Island vacation home as one of the assets federal prosecutors sought to seize. Cadden is serving a nine year federal prison sentence following his conviction on racketeering, conspiracy and mail fraud charges.
In a negotiated settlement of the forfeiture order, federal prosecutors agreed to allow the Caddens to retain the Rhode Island property in exchange for a payment of $369,000.
The home was purchased by the Caddens in 2009 for $785,000. It is currently assessed for $663,100.
Other properties covered in the forfeiture settlement include a home in Wrentham, Mass. which is currently on sale for $1.8 million. Half the proceeds from the sale of that property and two adjacent lots will go to the federal government.
Prosecutors also seized bank and investment accounts and a boat.
Contact: wfrochejr999@gmail.com
Friday, August 9, 2019
Cadden House Price Drops
By Walter F. Roche Jr.
The asking price on the home of jailed ex-pharmacist Barry J. Cadden has dropped from $2 million to $1.8 million, according to recent real estate listings in Massachusetts.
The new asking price is some $1 million below the original price of nearly $3 million.
Proceeds from the sale of the 9,000 square foot home in Wrentham, Mass. is the subject of a forfeiture order imposed following Cadden's conviction on racketeering, conspiracy and mail fraud charges.
Cadden is currently serving a nine year jail sentence at a federal prison in Pennsylvania. The charges stem from a two year probe of the deadly 2012 fungal meningitis outbreak caused by contaminated drugs produced at a drug compounding firm where Cadden served as president and part owner.
The property located at 13 Manchester Drive in the Boston suburb of Wrentham has five bedrooms, 5.5 baths a two acre lot and a salt water heated gunnite pool.
Federal prosecutors initially sought a $7.5 million forfeiture order which included the contents of several bank and investment accounts, along with jewelry, a Rhode Island seaside home, a boat and Cadden's BMW.
Lawyers for the Caddens and federal prosecutors subsequently reached a negotiated agreement in October of 2018 which allowed the Caddens to retain the Rhode Island property in exchange for a $369,000 payment. The revised order generally granted half the value of jointly owned properties to Cadden's wife Lisa.
Prosecutors have also sought $74 million more in restitution from Cadden and others involved in the New England Compounding Center, but U.S. District Judge Richard G. Stearns put that request on hold pending the completion of cases against other defendants.
According to the real estate listings, the Cadden's Wrentham residence has been on the market for 225 days. It was built in 2008.
Prosecutors have expressed hopes that restitution funds be earmarked for victims of the outbreak.
Contact: wfrochejr999@gmail.com
Thursday, August 8, 2019
Hospital Refused State Record Request
By Walter F. Roche Jr.
When state surveyors showed up at a rural Pennsylvania hospital and asked to look at patient safety and related records they were told they couldn't have them because the records were "confidential and protected."
In fact on three successive days in early June the state surveyors got the same response from officials of the Guthrie Towanda Memorial Hospital. On the next try they were given records but with large sections blacked out.
Left unreadable were sections of the minutes covering discussions and conclusions.
The confrontation earned the 35-bed hospital a citation for failing to comply with state licensing requirements.
"The facility was not able to provide this information because the information was considered confidential and protected," the inspection report states.
The records requested were meeting minutes for committees the hospital is required to maintain for patient safety, performance improvement and infection control.
Subsequently the hospital, located in Towanda, filed a plan of correction in which they promised to provide unredacted copies of the requested minutes by July 30.
The hospital was also cited for installing new imaging equipment without first notifying the state.
Tuesday, August 6, 2019
Indiana Outbreak Cases Back to Square One
By Walter F. Roche Jr.
Two Indiana courts have ruled that malpractice claims by victims of a deadly 2012 outbreak must first have their cases screened by a panel of doctors before they can pursue them in a courtroom.
The decisions in superior courts in Elkhart and Saint Joseph County mean that more than 100 cases will need to be reviewed one by one by a panel of three physicians.
Calling it a "minor setback," Douglas Small, whose law firm represents some 80 victims, said the courts rejected, at least for the moment, the argument that two Indiana clinics engaged in negligence or malpractice as a matter of law.
The decision comes some seven years after the fungal meningitis outbreak surfaced. Indiana was one of some 20 states where victims were stricken with fungal meningitis caused by steroids contaminated with deadly fungi. There were 93 victims in Indiana, according to the latest available data.
Small wrote in an email response to questions that victims' attorneys had argued that the clinics, including ASC Surgical Ventures and Orthopedic and Sports Medicine Center, failed to comply with the mandated state and federal procedures for use of prescription drugs when they purchased and dispensed the tainted steroids.
For instance, he said, they failed to comply with "the requirement that an individual prescription be issued for each patient for each drug obtained from a pharmacy."
That failure, he added, assisted the New England Compounding Center, which produced the drugs, to sell drugs in bulk, but still avoid stricter federal regulations.
He said each case will now be brought before a three physician panel to determine whether the clinics deviated from the standard of care.
Following that, the cases will then be brought back to court where Small said he will once again argue that the clinics were guilty of negligence as a matter of law.
Contact: wfrochejr999@gmail.com
Y
Two Indiana courts have ruled that malpractice claims by victims of a deadly 2012 outbreak must first have their cases screened by a panel of doctors before they can pursue them in a courtroom.
The decisions in superior courts in Elkhart and Saint Joseph County mean that more than 100 cases will need to be reviewed one by one by a panel of three physicians.
Calling it a "minor setback," Douglas Small, whose law firm represents some 80 victims, said the courts rejected, at least for the moment, the argument that two Indiana clinics engaged in negligence or malpractice as a matter of law.
The decision comes some seven years after the fungal meningitis outbreak surfaced. Indiana was one of some 20 states where victims were stricken with fungal meningitis caused by steroids contaminated with deadly fungi. There were 93 victims in Indiana, according to the latest available data.
Small wrote in an email response to questions that victims' attorneys had argued that the clinics, including ASC Surgical Ventures and Orthopedic and Sports Medicine Center, failed to comply with the mandated state and federal procedures for use of prescription drugs when they purchased and dispensed the tainted steroids.
For instance, he said, they failed to comply with "the requirement that an individual prescription be issued for each patient for each drug obtained from a pharmacy."
That failure, he added, assisted the New England Compounding Center, which produced the drugs, to sell drugs in bulk, but still avoid stricter federal regulations.
He said each case will now be brought before a three physician panel to determine whether the clinics deviated from the standard of care.
Following that, the cases will then be brought back to court where Small said he will once again argue that the clinics were guilty of negligence as a matter of law.
Contact: wfrochejr999@gmail.com
Y
Monday, August 5, 2019
Douglas and Carla Conigliaro's Beacon Hill Condo
Condo Purchased Just Before Outbreak
Purchased April 2012 for $4,195,000 Current Value $7,469,128
(Place this url in your address line)
https://www.redfin.com/MA/Boston/128-Beacon-St-02116/unit-L/home/11838633
Wednesday, November 9, 2016
Conigliaros Get Fines and Probation
By Walter F. Roche Jr.
A federal judge today sentenced the majority owner of a defunct drug compounding firm blamed for a deadly fungal meningitis outbreak to one year of probation and a $4,500 fine
The sentence was imposed by U.S. District Judge Richard Stearns against Carla Conigliaro, 53, of Dedham, Mass. the majority owner of the New England Compounding Center.
Her husband, Douglas Conigliaro, 55, who headed a related sale company, was sentenced to two years probation and a $55,000 fine.
The sentences were the same as recommended by federal prosecutors under a plea agreement in which they entered guilty pleas to violating a federal law requiring that bank withdrawals in excess of $10,000 be reported to the federal government.
They admitted to structuring withdrawals under $10,000 from bank accounts to avoid triggering the reporting requirement.
Under the plea deal Carla Conigliaro pleaded guilty to violating the structuring law with withdrawals totaling $4,600.75 while her husband admitted to $119,647 in structured withdrawals.
As part of that agreement federal prosecutors agreed to drop several additional structuring charges.
Though she was the majority shareholder and a board member, prosecutors said she was not involved in the day-to-day operations of NECC.
NECC has been blamed for the 2012 fungal meningitis outbreak that sickened 778 patients across the country, killing at least 77 of them.
The company shipped thousands of vials of fungus riddled methylprednisolone acetate to health providers across the country.
Another NECC owner, Barry Cadden, and a top company pharmacist, Glen Chin, are scheduled to go on trial on Jan. 5 on second degree murder charges. Others indicted following a federal grand jury probe of the outbreak, are scheduled for trial in April on lesser charges.
Contact: wfrochejr999@gmail.com
Posted by meningitis-etc.blogspot.com at 2:18 PM
Pharmacopeia Case 1:14-cr-10363-RGS *SEALED* Document 1 Filed 12/16/14 Page 6 of 73 15. The defendant CARLA R. CONIGLIARO ("CARLA CONIGLIARO") was an individual residing in Winter Park, Florida and Dedham, Massachusetts. CARLA CONIGLIARO was the majority shareholder ofNECC, and served as a dir ector ofNECC.
16. The defendant DOUGLAS A. CONIGLIARO ("DOUG CONIGLIARO") was an individual residing in Winter Park, Florida and Dedham, Massachusetts. DOUG CONIGLIARO was the husband of CARLA CONIGLIARO. DOUG CONIGLIARO was an owner and director of MSM, and served as MSM's President.
Sunday, August 4, 2019
Updated NECC Indictment Scorecard
Friday, May 3, 2019
Latest NECC Indictment Scorecard
Here are the names of those indicted in the probe of the New England Compounding Center and the current status of their cases.
Barry J. Cadden: convicted of racketeering, racketeering conspiracy, mail fraud and violations of the Food Drug and Cosmetic Act (FDC Act). (Cleared of second degree murder)Currently serving nine year federal prison sentence. Release date June 6, 2025.
Glenn Chin: found guilty of racketeering, racketeering conspiracy, mail fraud and violations of the FDCA. (Cleared of second degree murder) Serving an eight year federal prison sentence. Release date Feb. 26, 2025.
Gene Svirskiy: Convicted of racketeering, racketeering conspiracy, violations of the FDCA. Began serving 30 month sentence. Release date Aug. 26, 2021
Scott M. Connolly: entered guilty plea to nine counts of mail fraud. Sentenced to two years probation.
Sharon P. Carter: convicted of conspiracy to defraud the federal government. Acquitted on appeal.
Alla V. Stepanets: convicted of six violation of the FDCA. Sentenced to one year probation.
Gregory A. Conigliaro: convicted of conspiracy to defraud the U.S. Food and Drug Administration. Acquitted on appeal.
Robert A. Ronzio: entered guilty plea to conspiracy to defraud the FDA. Sentencing delayed indefinitely.
Christopher Leary: convicted of mail fraud and violations of the FDCA. Sentenced to eight months home confinement.
Kathy S. Chin: Convicted of four violations of the FDCA with intent to defraud. Sentencing delayed pending appeal.
Michelle L. Thomas: Convicted of two violations of the FDCA with intent to defraud. Sentencing delayed pending appeal.
Carla R. Conigliaro: Pleaded guilty to violations of financial transaction reporting laws. Sentenced to probation
Douglas A. Conigliaro Pleaded guilty to violations of financial transaction reporting laws. Sentenced to probation.
Joseph M. Evanosky: cleared of all charges.
Contact:wfrochejr999@gmail.com
Latest NECC Indictment Scorecard
Here are the names of those indicted in the probe of the New England Compounding Center and the current status of their cases.
Barry J. Cadden: convicted of racketeering, racketeering conspiracy, mail fraud and violations of the Food Drug and Cosmetic Act (FDC Act). (Cleared of second degree murder)Currently serving nine year federal prison sentence. Release date June 6, 2025.
Glenn Chin: found guilty of racketeering, racketeering conspiracy, mail fraud and violations of the FDCA. (Cleared of second degree murder) Serving an eight year federal prison sentence. Release date Feb. 26, 2025.
Gene Svirskiy: Convicted of racketeering, racketeering conspiracy, violations of the FDCA. Began serving 30 month sentence. Release date Aug. 26, 2021
Scott M. Connolly: entered guilty plea to nine counts of mail fraud. Sentenced to two years probation.
Sharon P. Carter: convicted of conspiracy to defraud the federal government. Acquitted on appeal.
Alla V. Stepanets: convicted of six violation of the FDCA. Sentenced to one year probation.
Gregory A. Conigliaro: convicted of conspiracy to defraud the U.S. Food and Drug Administration. Acquitted on appeal.
Robert A. Ronzio: entered guilty plea to conspiracy to defraud the FDA. Sentencing delayed indefinitely.
Christopher Leary: convicted of mail fraud and violations of the FDCA. Sentenced to eight months home confinement.
Kathy S. Chin: Convicted of four violations of the FDCA with intent to defraud. Sentencing delayed pending appeal.
Michelle L. Thomas: Convicted of two violations of the FDCA with intent to defraud. Sentencing delayed pending appeal.
Carla R. Conigliaro: Pleaded guilty to violations of financial transaction reporting laws. Sentenced to probation
Douglas A. Conigliaro Pleaded guilty to violations of financial transaction reporting laws. Sentenced to probation.
Joseph M. Evanosky: cleared of all charges.
Contact:wfrochejr999@gmail.com
Subscribe to:
Posts (Atom)